GLP
Research

The Incretin Receptor Family

"Incretin" research centers on a small group of peptide hormone receptors that participate in metabolic signaling. Three receptors anchor most of this work:

• GLP-1 receptor — the glucagon-like peptide-1 receptor, the most extensively studied of the three.
• GIP receptor — the glucose-dependent insulinotropic polypeptide receptor.
• Glucagon receptor — studied for its role in hepatic and energy-expenditure signaling pathways.

Research-grade peptides in this space are engineered analogs designed to bind one or more of these receptors with high affinity and extended stability relative to the native hormones. They are studied in receptor-binding assays, cell-based models and other in-vitro systems.

Single, Dual and Triple Agonists

Incretin research peptides are commonly grouped by how many of the three receptors they engage:

• Single agonists bind one receptor. Semaglutide is the most studied GLP-1 single agonist — a 31-residue analog with a fatty-acid chain that extends its half-life in research models.
• Dual agonists bind two receptors. Tirzepatide is the reference dual GIP / GLP-1 receptor agonist studied in this class.
• Triple agonists bind all three. Retatrutide is the reference triple GIP / GLP-1 / glucagon receptor agonist.

The research interest in moving from single to dual to triple agonism is the ability to study how simultaneous engagement of multiple incretin pathways changes a compound's signaling profile in controlled models.

Mechanism Context

At the receptor level, incretin agonists are studied as ligands that activate G-protein-coupled receptors. Activation initiates intracellular signaling cascades — most notably cyclic AMP (cAMP) accumulation — which researchers quantify in cell-based reporter assays. Comparative potency across compounds is typically expressed through standard pharmacology measures such as EC50 values derived from these assays.

Structural engineering — residue substitutions, fatty-acid acylation and backbone modifications — is what gives these analogs their extended stability and receptor selectivity profiles compared with the native peptide hormones. This is why two compounds that both "target GLP-1" can behave very differently in a research setting.

Research Applications

Within laboratory research, incretin agonist peptides are commonly studied in:

• Receptor-binding and receptor-activation assays
• cAMP and downstream signaling readouts in cell-based models
• Comparative potency and selectivity profiling across receptor subtypes
• Peptide stability, formulation and reconstitution research
• Structure-activity relationship (SAR) studies

Handling & Storage

Incretin research peptides are typically supplied lyophilized (freeze-dried). Lyophilized material is the most stable form and should be kept cold and dry until use. Once reconstituted with bacteriostatic water, working solutions are far more sensitive to temperature and time. See the Lyophilized Storage Guide for full protocols, and the Reconstitution Calculator for preparing working solutions.